Dr. Kosinski: “GI is more vulnerable today than it was before” (SF interview)

Dr. Larry Kosinski needs no introduction. As a leader, he’s known for innovating, for breaking away from the norm and be a guiding light for the industry. After a successful private practice career, he helped his group transition to a PE platform to work on SonarMD, a venture-funded company he founded. Now, he’s onto a surprising new startup, a stool-smelling e-nose called Voconomics (patent filed).

In this freewheeling interview, we chat about everything that GI doctors must pay attention to. The risks of running non-diversified “colonoscopy factories” (as he calls them). The shift to digital that would catch most of the industry by surprise. How doctors can find the time from their busy lives to innovate by mastering the basics. And finally his take on private equity.

This is such an important interview. It could quite easily alter the trajectory of many GI careers. It’s time to wake up to the vulnerability that private practice GI is in. Dr. Kosinski’s message is quite clear. Listen closely.

◘ Update on SonarMD

◘ Different initiatives Dr. Kosinski is involved with

◘ Is the average gastroenterologist aware of the impact of digital disruption in gastroenterology?

◘ Are GI practices still “colonoscopy factories?”

◘ A threat to GI

◘ “Right now, I don’t see the GI practices engaging with the digital health world”

◘ Are GI practices more vulnerable or less vulnerable to changes in the last couple of years?

◘ “The market will find the lowest cost way of providing services”

◘ Would disruption in GI appear to be all of a sudden?

◘ Thoughts on vulnerabilities within digital health trends (RNA test for cancer screening, AI, etc)

◘ “Patients will tell you that their IBD flare was associated with the change in the smell of their stool”

◘ Dr. Kosinski talks about his new e-nose startup: Vocnomics